The transit of T cell-activated B cells through the germinal center (GC) is controlled by sequential activation and repression of key transcription factors, executing the pre- and post-GC B cell program. B cell lymphoma (BCL) 6 and IFN regulatory factor (IRF) 8 are necessary for GC formation and for its molecular activity in Pax5+PU.1+ B cells. IRF4, which is highly expressed in BCL6- GC B cells, is necessary for class switch recombination and the plasma cell differentiation at exit from the GC. In this study, we show at the single-cell level broad coexpression of IRF4 with BCL6, Pax5, IRF8, and PU.1 in pre- and post-GC B cells in human and mouse. IRF4 is down-regulated in BCL6+ human GC founder cells (IgD+CD38+), is absent in GC centroblasts, and is re-expressed in positive regulatory domain 1-positive centrocytes, which are negative for all the B cell transcription factors. Activated (CD30+) and activation-induced cytidine deaminase-positive extrafollicular blasts coexpress Pax5 and IRF4. PU.1-negative plasma cells and CD30+ blasts uniquely display the conformational epitope of IRF4 recognized by the MUM1 Ab, an epitope that is absent from any other IRF4+PU.1+ lymphoid and hemopoietic subsets. Low grade B cell lymphomas, representing the malignant counterpart of pre- and post-GC B cells, accordingly express IRF4. However, a fraction of BCL6+ diffuse large B cell lymphomas express IRF4 bearing the MUM1 epitope, indicative of a posttranscriptional modification of IRF4 not seen in the normal counterpart.

Cattoretti, G., Shaknovich, R., Smith, P., Jäck, H., Murty, V., Alobeid, B. (2006). Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. JOURNAL OF IMMUNOLOGY, 177(10), 6930-6939 [10.4049/jimmunol.177.10.6930].

Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance

CATTORETTI, GIORGIO;
2006

Abstract

The transit of T cell-activated B cells through the germinal center (GC) is controlled by sequential activation and repression of key transcription factors, executing the pre- and post-GC B cell program. B cell lymphoma (BCL) 6 and IFN regulatory factor (IRF) 8 are necessary for GC formation and for its molecular activity in Pax5+PU.1+ B cells. IRF4, which is highly expressed in BCL6- GC B cells, is necessary for class switch recombination and the plasma cell differentiation at exit from the GC. In this study, we show at the single-cell level broad coexpression of IRF4 with BCL6, Pax5, IRF8, and PU.1 in pre- and post-GC B cells in human and mouse. IRF4 is down-regulated in BCL6+ human GC founder cells (IgD+CD38+), is absent in GC centroblasts, and is re-expressed in positive regulatory domain 1-positive centrocytes, which are negative for all the B cell transcription factors. Activated (CD30+) and activation-induced cytidine deaminase-positive extrafollicular blasts coexpress Pax5 and IRF4. PU.1-negative plasma cells and CD30+ blasts uniquely display the conformational epitope of IRF4 recognized by the MUM1 Ab, an epitope that is absent from any other IRF4+PU.1+ lymphoid and hemopoietic subsets. Low grade B cell lymphomas, representing the malignant counterpart of pre- and post-GC B cells, accordingly express IRF4. However, a fraction of BCL6+ diffuse large B cell lymphomas express IRF4 bearing the MUM1 epitope, indicative of a posttranscriptional modification of IRF4 not seen in the normal counterpart.
Articolo in rivista - Articolo scientifico
B-Lymphocyte Subsets/chemistry/*immunology/*metabolism;Cell Movement/genetics/*immunology;DNA-Binding Proteins/*biosynthesis/deficiency/physiology;Flow Cytometry;Germinal Center/*cytology/*immunology/metabolism;Humans;Immunohistochemistry;Interferon Regulatory Factors/*biosynthesis/deficiency/physiology;Lymphoid Tissue/cytology/immunology/metabolism;Lymphoma, B-Cell/chemistry/immunology/pathology;Mice;Mice, Inbred C57BL;Mice, Knockout;Organ Specificity/genetics/immunology;Palatine Tonsil/cytology/immunology/metabolism;ranscription Factors/*biosynthesis/deficiency/physiology;Tumor Cells, Cultured
English
15-nov-2006
177
10
6930
6939
none
Cattoretti, G., Shaknovich, R., Smith, P., Jäck, H., Murty, V., Alobeid, B. (2006). Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. JOURNAL OF IMMUNOLOGY, 177(10), 6930-6939 [10.4049/jimmunol.177.10.6930].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/6502
Citazioni
  • Scopus 113
  • ???jsp.display-item.citation.isi??? 108
Social impact